[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368481-105":59,"doc-detail-368481-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","significance-of-androgen-receptor-and-its-potential-for-anti-androgenandrogen-receptor-antagonist-therapy-in-ovarian-cancers","Significance of androgen receptor and its potential for anti-androgen/androgen receptor-antagonist therapy in ovarian cancers","","Study evaluates androgen receptor (AR) expression across ovarian cancer subtypes and compares AR status with estrogen receptor (ER) and progesterone receptor (PR). AR, ER, and PR were measured in 62 cases spanning low-grade serous, high-grade serous, clear cell, endometrioid, and granulosa cell tumors, then related to p53 and BMI. Most tumors showed concordant AR with ER and/or PR, while AR positivity appeared in subsets lacking ER/PR. Findings support AR as a potential biomarker and therapeutic target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/significance-of-androgen-receptor-and-its-potential-for-anti-androgenandrogen-receptor-antagonist-therapy-in-ovarian-cancers/368481/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/significance-of-androgen-receptor-and-its-potential-for-anti-androgenandrogen-receptor-antagonist-therapy-in-ovarian-cancers/368481.png","ImageObject",300,407,{"name":92,"@type":93},"Maya Linwood","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of the study?","Question",{"text":112,"@type":113},"To assess androgen receptor (AR) expression in different ovarian cancer types and compare it with estrogen and progesterone receptor status.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were AR, ER, and PR expressions evaluated?",{"text":117,"@type":113},"Expressions of AR, ER, and PR were assessed in 62 ovarian cancer cases categorized by histological subtype, followed by comparison with p53 and BMI using Fisher’s Exact test.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the results show about AR compared with ER and PR?",{"text":121,"@type":113},"AR was concordant with ER and/or PR in most cases, with high positivity for AR in high-grade serous carcinomas and endometrioid carcinomas; rare cases showed AR positivity even when ER and PR were negative.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368481,1790202468,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084928432,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","OPEN ACCESS  \nCitation: Kim TH, Memarzadeh S, Vahdatshariatpanahi S, Ostrzega N, Kang Y, Moatamed NA (2025) Significance of androgen receptor and its potential for anti-androgen/ androgen receptor-antagonist therapy in ovarian cancers. PLoS One 20(5): e0322744. [https://](https://)[ ](https://)[doi.org/10.1371/journal.pone.0322744](doi.org/10.1371/journal.pone.0322744)  \n[Editor:](Editor: Sanaz Alaeejahromi)[ Sanaz Alaeejahromi](Editor: Sanaz Alaeejahromi), Shiraz University of Medical Sciences, IRAN, ISLAMIC REPUBLIC OF  \nReceived: July 21, 2024  \nAccepted: March 26, 2025  \nPublished: May 20, 2025  \nCopyright: © . This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.  \nData availability statement: The entire data set for this work, including the statistical analyses, is available online at Harvard Dataverse: [https://](https://)[ ](https://)[doi.org/10.7910/DVN/G6XQB4](doi.org/10.7910/DVN/G6XQB4)  \nRESEARCH ARTICLE  \nSignificance of androgen receptor and its potential for anti-androgen/androgen receptorantagonist therapy in ovarian cancers  \nTeresa H. Kim1, Sanaz Memarzadeh2,3,4,5,6, Saba Vahdatshariatpanahi1, Nora Ostrzega1, Yuna Kang1, NedaA. Moatamed1,4*  \n1 Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, 2 Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 3 UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California Los Angeles, Los Angeles, CA, 4 Johnson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, 5 Molecular Biology Institute, University of California Los Angeles, Los Angeles, CA, 6 VA Greater Los Angeles Healthcare System, Los Angeles, CA.  \n* [nmoatamed@mednet.ucla.edu](nmoatamed@mednet.ucla.edu)  \nAbstract  \nIntroduction  \nAndrogen promotes tumorigenesis in some cancers; however, androgen receptor (AR) is not commonly examined in ovarian cancers (OCs) . In this study, we evaluated AR expression among different types of OCs and compared the results to estrogen and progesterone receptors (ER & PR) .  \nMaterials and methods  \nAR, ER, and PR expressions were assessed in 62 cases which were categorized into: low-grade serous carcinoma (LGSCA), high-grade serous carcinoma (HGSCA), clear cell carcinoma (CCCA), ovarian endometrioid carcinoma (OECA), and granulosa cell tumor (GCT) . The hormone receptors were compared and evaluated in relation to p53 and body mass index (BMI) using Fisher’s Exact test.  \nResults  \nIn a majority of cases, expression ofAR was concordant with ER and/or PR. Positivity for all three receptors was observed in 100% of OECAs. AR expression was seen in 92% of HGSCAs as opposed to 88% and 44% for ER and PR. LGSCAs had expressed AR and ER (100%), and PR (70%) . In GCTs, positivity rates were 92%, 62%, and 92% for AR, ER, and PR. In rare cases of HGSCA and CCCA, AR was positive despite negative ER and PR.  \nPLOS One | [https://doi.org/10.1371/journal.pone.0322744](https://doi.org/10.1371/journal.pone.0322744) May 20, 2025 1 / 21  \nFunding: Dr. Sanaz Memarzadeh is supported by a Merit Award from the Department of Veteran Affairs (Grant Number: I01BX006019) . Dr. Sanaz Memarzadeh’s funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.  \nCompeting interests: The authors have declared that no competing interests exist.  \nConclusion  \nAR is expressed in a high percentage of OCs, even more frequently than ER and PR in certain high-grade histological types. Overall, our findings are similar to the results of recent studies ofAR expression in endometrial cancers. These findings support an important possible role for AR in OCs as a potential ma","cbCaisJ7zWAcQQCZ","https://ap.wps.com/l/cbCaisJ7zWAcQQCZ","pdf",3228076,21,"English","# Abstract\n# Introduction\n# Materials and methods\n# Results\n# Funding\n# Competing interests\n# Conclusion","[{\"question\":\"What is the main purpose of the study?\",\"answer\":\"To assess androgen receptor (AR) expression in different ovarian cancer types and compare it with estrogen and progesterone receptor status.\"},{\"question\":\"How were AR, ER, and PR expressions evaluated?\",\"answer\":\"Expressions of AR, ER, and PR were assessed in 62 ovarian cancer cases categorized by histological subtype, followed by comparison with p53 and BMI using Fisher’s Exact test.\"},{\"question\":\"What did the results show about AR compared with ER and PR?\",\"answer\":\"AR was concordant with ER and/or PR in most cases, with high positivity for AR in high-grade serous carcinomas and endometrioid carcinomas; rare cases showed AR positivity even when ER and PR were negative.\"}]","Significance of androgen receptor and its potential for anti-androgen/androgen receptor-antagonist therapy in ovarian cancers | PDF",1790177190,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/207260094c1062327b3918e27947298c.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ad011a1fb4bc5649792a2962a717656e.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2da2b1d0945d687d8eede3e4fb30f668.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14fde9211dc937101b4ff1ae784e5e61.webp",980,1268]